Publications by authors named "Rachel Andes"

Article Synopsis
  • - The study evaluated the effects of nivolumab (N) alone and nivolumab combined with ipilimumab (N + I) on patients with advanced gastrointestinal stromal tumors (GIST) who were resistant to prior treatment with imatinib.
  • - Out of 36 patients, the objective response rate was not higher than 15%; N showed a clinical benefit rate of 52.6% with a median progression-free survival of 11.7 weeks, while N + I had a lower clinical benefit rate of 31.3% and a median progression-free survival of 8.3 weeks.
  • - Despite not meeting the primary endpoint, some patients experienced long-term disease control, and both treatment reg
View Article and Find Full Text PDF

As demand increased for mental health services, especially in university counseling centers, providers have seen increasing numbers of clients. The effect of this increase on therapist caseloads is explored, with a recognition that past research on therapist caseloads lacks direct and fluctuating measures of caseload that reflect practice in naturalistic settings. Using a large dataset from a counseling center ( = 18,322), therapist caseload was conceptualized dynamically over rolling 30-day periods, using within-therapist counts of therapy sessions, unique clients seen, and the proportion of unique clients to sessions.

View Article and Find Full Text PDF